Aquestive Therapeutics, Inc. (AQST) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 130.18M | 149.27M | 151.67M | 81.72M | 89.17M | 88.22M | 96.57M | 104.01M | 113.38M | 40.97M | 42.46M | 39.79M |
| Cash & Short-Term Investments | 110.73M | 121.17M | 129.06M | 60.54M | 68.66M | 71.55M | 77.89M | 89.87M | 95.2M | 23.87M | 24.92M | 22.44M |
| Cash Only | 110.73M | 121.17M | 129.06M | 60.54M | 68.66M | 71.55M | 77.89M | 89.87M | 95.2M | 23.87M | 24.92M | 22.44M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 6.87M | 17.76M | 11.8M | 11.86M | 10.44M | 7.34M | 9.68M | 6M | 8.32M | 8.47M | 8.55M | 10.1M |
| Days Sales Outstanding | 76.72 | 104.49 | 85 | 101.47 | 91.8 | 66.01 | 53.27 | 32.42 | 63.4 | 59.29 | 65.99 | 60.66 |
| Inventory | 8.07M | 6.17M | 7.88M | 8.13M | 7.2M | 6.04M | 7.02M | 6.97M | 7.73M | 6.77M | 7.08M | 5.95M |
| Days Inventory Outstanding | 184.66 | 110.77 | 163.43 | 152.86 | 163.17 | 132.96 | 145.01 | 147.78 | 150.35 | 136.14 | 124.91 | 88.92 |
| Other Current Assets | 4.52M | 4.17M | 2.92M | 1.2M | 2.87M | 3.29M | 1.97M | 1.18M | 2.12M | 1.85M | 1.91M | 1.3M |
| Total Non-Current Assets | 10.94M | 11.16M | 11.89M | 11.98M | 13.06M | 13.2M | 13.39M | 13.59M | 16.14M | 16.45M | 16.99M | 17.21M |
| Property, Plant & Equipment | 8.31M | 8.51M | 8.69M | 8.77M | 8.85M | 8.98M | 9.16M | 9.36M | 9.49M | 9.74M | 10.22M | 10.38M |
| Fixed Asset Turnover | 1.72x | 1.51x | 1.47x | 1.14x | 0.98x | 1.31x | 1.46x | 2.13x | 1.25x | 1.32x | 1.26x | 1.32x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.24M | 1.28M | 1.32M | 1.36M |
| Long-Term Investments | 2M | 2M | 2M | 0 | 3M | 3M | 3M | 0 | 0 | 4M | 0 | 0 |
| Other Non-Current Assets | 635K | 642K | 1.2M | 3.21M | 1.22M | 1.22M | 1.23M | 4.24M | 5.42M | 1.44M | 5.45M | 5.47M |
| Total Assets | 141.13M | 160.43M | 163.56M | 93.7M | 102.23M | 101.42M | 109.96M | 117.61M | 129.52M | 57.42M | 59.45M | 56.99M |
| Asset Turnover | 0.10x | 0.08x | 0.10x | 0.10x | 0.09x | 0.11x | 0.12x | 0.16x | 0.13x | 0.23x | 0.22x | 0.22x |
| Asset Growth % | 38.04% | 58.17% | 48.75% | -20.33% | -21.07% | 76.64% | 84.97% | 106.35% | 111.35% | 0.61% | 14.66% | 1.21% |
| Total Current Liabilities | 31.75M | 47.61M | 25.57M | 23.16M | 18.3M | 18.86M | 15.15M | 13.89M | 18.06M | 18.31M | 24.06M | 38.65M |
| Accounts Payable | 11.89M | 29.86M | 10.87M | 11.95M | 12.28M | 10.29M | 7.57M | 5.7M | 10.52M | 8.93M | 9.99M | 10.69M |
| Days Payables Outstanding | 541.6 | 321.01 | 232.92 | 241.73 | 278.07 | 181.75 | 137.55 | 163.05 | 201.62 | 186.01 | 198.29 | 159.04 |
| Short-Term Debt | 15.32M | 11.63M | 8.49M | 3.18M | 27K | 26K | 25K | 24K | 23K | 22K | 4.61M | 18.36M |
| Deferred Revenue (Current) | 1.09M | 1.09M | 1.09M | 1.09M | 1.05M | 1.05M | 1.05M | 1.05M | 1.55M | 1.55M | 2.64M | 3.99M |
| Other Current Liabilities | 1.38M | 5.03M | 1.43M | 4.89M | 3.28M | 1M | 4.46M | 3.67M | 2.64M | 5.12M | 3.82M | 3.8M |
| Current Ratio | 4.10x | 3.14x | 5.93x | 3.53x | 4.87x | 4.68x | 6.37x | 7.49x | 6.28x | 2.24x | 1.76x | 1.03x |
| Quick Ratio | 3.85x | 3.01x | 5.62x | 3.18x | 4.48x | 4.36x | 5.91x | 6.98x | 5.85x | 1.87x | 1.47x | 0.88x |
| Cash Conversion Cycle | -280.21 | -105.76 | 15.51 | 12.61 | -23.11 | 17.22 | 60.73 | 17.15 | 12.13 | 9.43 | -7.4 | -9.47 |
| Total Non-Current Liabilities | 143.43M | 146.48M | 142.09M | 143.13M | 144.87M | 142.72M | 140.23M | 139.19M | 147.77M | 145.6M | 138.32M | 124.99M |
| Long-Term Debt | 114.1M | 115.48M | 115.86M | 31.84M | 33.75M | 32.5M | 31.25M | 30.01M | 28.76M | 27.51M | 34.55M | 20.8M |
| Capital Lease Obligations | 4.16M | 4.34M | 4.51M | 4.67M | 4.82M | 4.97M | 5.11M | 5.24M | 5.28M | 5.4M | 5.51M | 5.61M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 6.05M | 7.27M | 2.06M | 86.69M | 86.55M | 85.24M | 83.6M | 82.19M | 81.77M | 80.34M | 65.52M | 65.46M |
| Total Liabilities | 175.18M | 194.09M | 167.67M | 166.29M | 163.16M | 161.58M | 155.38M | 153.08M | 165.82M | 163.91M | 162.38M | 163.65M |
| Total Debt | 133.58M | 131.44M | 128.86M | 40.26M | 39.13M | 38M | 36.87M | 35.72M | 34.48M | 33.32M | 45.04M | 45.12M |
| Net Debt | 22.84M | 10.28M | -201K | -20.28M | -29.52M | -33.54M | -41.02M | -54.15M | -60.72M | 9.45M | 20.12M | 22.68M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | 137.40x | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | -208.26x | - | - | - | - |
| Interest Coverage | -1.07x | -6.75x | -2.69x | -2.66x | -4.53x | -3.04x | -1.74x | 0.35x | -2.05x | -1.48x | -0.66x | -2.86x |
| Total Equity | -34.05M | -33.66M | -4.11M | -72.59M | -60.93M | -60.16M | -45.42M | -35.48M | -36.3M | -106.49M | -102.93M | -106.65M |
| Equity Growth % | 44.11% | 44.04% | 90.95% | -104.6% | -67.85% | 43.51% | 55.87% | 66.73% | 66.77% | 10.18% | 4.54% | -10.68% |
| Book Value per Share | -0.28 | -0.28 | -0.04 | -0.73 | -0.64 | -0.66 | -0.50 | -0.39 | -0.49 | -1.55 | -1.59 | -1.86 |
| Total Shareholders' Equity | -34.05M | -33.66M | -4.11M | -72.59M | -60.93M | -60.16M | -45.42M | -35.48M | -36.3M | -106.49M | -102.93M | -106.65M |
| Common Stock | 124K | 122K | 121K | 99K | 99K | 91K | 91K | 91K | 90K | 69K | 67K | 62K |
| Retained Earnings | -455.06M | -447M | -415.14M | -399.69M | -386.14M | -363.21M | -346.16M | -334.65M | -331.9M | -319.08M | -310.97M | -308.93M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |